Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    13.75
    -0.04 (-0.29%)
    At close: Aug 18, 2025, 10:46 AM

    Crescent Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025
    Period Ending Jun 30, 2025
    Cash & Equivalents
    		 152.65M
    Short-Term Investments
    		 n/a
    Long-Term Investments
    		 n/a
    Other Long-Term Assets
    		 1.41M
    Receivables
    		 n/a
    Inventory
    		 n/a
    Other Current Assets
    		 1.58M
    Total Current Assets
    		 154.23M
    Property-Plant & Equipment
    		 1.8M
    Goodwill & Intangibles
    		 n/a
    Total Long-Term Assets
    		 3.21M
    Total Assets
    		 157.43M
    Account Payables
    		 1.65M
    Deferred Revenue
    		 n/a
    Short-Term Debt
    		 n/a
    Other Current Liabilities
    		 3.66M
    Total Current Liabilities
    		 16.75M
    Long-Term Debt
    		 n/a
    Other Long-Term Liabilities
    		 n/a
    Total Long-Term Liabilities
    		 1.43M
    Total Liabilities
    		 18.18M
    Total Debt
    		 1.64M
    Common Stock
    		 14K
    Retained Earnings
    		 -54.8M
    Comprehensive Income
    		 n/a
    Shareholders Equity
    		 139.25M
    Total Investments
    		 n/a

    Add to Watchlist